Actionable news
0
All posts from Actionable news
Actionable news in AMDA: AMEDICA CORPORATION,

Clovis Oncology (CLVS) Stock Plunging On Anticipated Delay in FDA Drug Approval

NEW YORK (TheStreet) -- Clovis Oncology (CLVS) stock is plummeting by 68.56% to $31.26 in late morning trading on Monday, after the U.S. Food and Drug Administration delayed approval of the company's lung cancer drug.

During the bio-pharmaceutical company's mid-cycle communication meeting with the FDA last week, the regulatory agency asked for additional clinical data regarding a lung cancer drug under clinical trial, according to a company statement.

The patients...


More